Importer of Controlled Substances; Notice of Application, 30620-30621 [E9-15228]
Download as PDF
30620
Federal Register / Vol. 74, No. 122 / Friday, June 26, 2009 / Notices
herein, is to apprise the public as well
as governmental agencies, associations
and all other organizations and
individuals interested in historic
preservation, of the properties added to,
or determined eligible for listing in, the
National Register of Historic Places from
May 4, to May 8, 2009.
For further information, please
contact Edson Beall via: United States
Postal Service mail, at the National
Register of Historic Places, 2280,
National Park Service, 1849 C St., NW.,
Washington, DC 20240; in person (by
appointment), 1201 Eye St., NW., 8th
floor, Washington DC 20005; by fax,
202–371–2229; by phone, 202–354–
2255; or by e-mail,
Edson_Beall@nps.gov.
Dated: June 11, 2009.
J. Paul Loether,
Chief, National Register of Historic Places/
National Historic Landmarks Program.
KEY: State, County Property Name, Address/
Boundary, City, Vicinity, Reference Number,
Action, Date, Multiple Name
CALIFORNIA
Polk County
DEPARTMENT OF JUSTICE
National Biscuit Company Building, 1001
Cherry St., Des Moines, 09000273, LISTED,
5/06/09
Drug Enforcement Administration
KANSAS
Leavenworth County
Leavenworth Terminal Railway & Bridge
Company Freight Depot, 306 S. 7th St.,
Leavenworth, 09000274, LISTED, 5/06/09
(Railroad Resources of Kansas MPS)
Marion County
Florence Water Tower, 525 W. 5th St., E. of
US 77 at jct. US 50 & 77, Florence,
09000275, LISTED, 5/06/09
Wilkie, Grace, House, 4230 E. English St.,
Wichita, 09000278, LISTED, 5/06/09
MASSACHUSETTS
Essex County
Blakeley Building, 475–479 Essex St.,
Lawrence, 09000299, LISTED, 5/04/09
COLORADO
MISSOURI
San Miguel County
Lewis Mill, 3.5 mi. SE of Telluride at the
head of Bridal Veil Basin, Telluride
vicinity, 09000267, LISTED, 5/06/09
(Mining Industry in Colorado, MPS)
St. Louis Independent City
GEORGIA
Niagara County
Dawson County
Gilleland, Boyd and Sallie, House, 3
Shepard’s Ln., Dawsonville, 09000268,
LISTED, 5/06/09
House at 8 Berkley Drive, 8 Berkley Dr.,
Lockport, 09000287, LISTED, 5/04/09
Gill, William A., Building, 622 Olive St., St.
Louis, 09000282, LISTED, 5/08/09
NEW YORK
Suffolk County
IDAHO
Cauldwell, William, House, 51 Peconic Ave.,
Noyac, 09000305, LISTED, 5/04/09
NORTH CAROLINA
Cleveland County
Margrace Mill Village Historic District, 101–
117, 102–120 Cloninger St., 101–113, 102–
116, 200 Fulton Dr., 145 Ark St., 101–107,
102–114 Water Oak St., Kings Mountain,
09000288, LISTED, 5/06/09
Blaine County
Chase, Eben S. and Elizabeth S., House, 203
E. Bullion St., Hailey, 09000292, LISTED,
5/05/09
Davie County
Latah County
Snow, Arthur, House, 2949 Clyde Rd.,
Moscow, 09000294, LISTED, 5/05/09
VIRGINIA
Barnhardt, George E., House, 291 Hartley Rd.,
Mocksville vicinity, 09000289, LISTED, 5/
04/09
James City County
IOWA
Polk County
Clemens Automobile Company Building, 200
10th St., Des Moines, 09000272, LISTED,
5/06/09
Norge Train Depot, 7770 Croaker Rd.,
Williamsburg vicinity, 08000256, LISTED,
5/05/09
[FR Doc. E9–15227 Filed 6–25–09; 8:45 am]
VerDate Nov<24>2008
16:39 Jun 25, 2009
Jkt 217001
Drug
Methamphetamine (1105) ............
Phenylacetone (8501) ..................
Raw Opium (9600) .......................
Concentrate of Poppy Straw
(9670).
Schedule
II
II
II
II
Essex County
Los Angeles County
Neutra, Richard and Dion, VDL Research
House II, 2300 Silver Lake Blvd., Los
Angeles, 03000774, LISTED, 5/08/09
Rockdale County
Parker, Aaron and Margaret, Jr., House, 4835
Flat Bridge Rd., SW., Stockbridge vicinity,
09000271, LISTED, 5/06/09
Pursuant to Title 21 Code of Federal
Regulations 1301.34(a), this is notice
that on May 8, 2009, Chattem
Chemicals, Inc., 3801 St. Elmo Avenue,
Building 18, Chattanooga, Tennessee
37409, made application by renewal to
the Drug Enforcement Administration
(DEA) for registration as an importer of
the basic classes of controlled
substances listed in schedule II:
Sedgwick County
North Canal Historic District (Boundary
Increase), Roughly bounded by the
Merrimack and Spicket rivers, North Canal,
and Broadway, Lawrence, 09000280,
LISTED, 5/08/09
Fulton County
Ellis, Rutherford and Martha, House, 543 W.
Wesley Rd., NW., Atlanta, 09000269,
LISTED, 5/06/09
Importer of Controlled Substances;
Notice of Application
BILLING CODE P
PO 00000
Frm 00121
Fmt 4703
Sfmt 4703
The company plans to import the
listed controlled substances to
manufacture bulk controlled substances
for sale to its customers.
No comments, objections, or requests
for any hearings will be accepted on any
application for registration or reregistration to import crude opium,
poppy straw, concentrate of poppy
straw, and coca leaves. As explained in
the Correction to Notice of Application
pertaining to Rhodes Technologies, 72
FR 3417 (2007), comments and requests
for hearings on applications to import
narcotic raw material are not
appropriate.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substances listed in schedule I or II,
which fall under the authority of section
1002(a)(2)(B) of the Act (21 U.S.C.
952(a)(2)(B)) may, in the circumstances
set forth in 21 U.S.C. 958(i), file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such comments or objections
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than July 27, 2009.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
E:\FR\FM\26JNN1.SGM
26JNN1
Federal Register / Vol. 74, No. 122 / Friday, June 26, 2009 / Notices
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substances in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a), 21 U.S.C. 823(a), and 21
CFR § 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: June 22, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–15228 Filed 6–25–09; 8:45 am]
BILLING CODE 4410–09–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 USC 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in schedule I or II, and prior
to issuing a regulation under 21 U.S.C.
952(a)(2) authorizing the importation of
such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with Title
21, Code of Federal Regulations
1301.34(a), this is notice that on May 22,
2009, Noramco, Inc., Division of OrthoMcNeil, Inc., 500 Swedes Landing Road,
Wilmington, Delaware 19801, made
application by letter to the Drug
Enforcement Administration (DEA) to
be registered as an importer of
Tapentadol (9780), a basic class of
controlled substance listed in schedule
II.
The company plans to import an
intermediate of the basic class listed for
the bulk manufacture of Tapentadol
which it will distribute to its customers.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic class of controlled substance
may file comments or objections to the
issuance of the proposed registration
and may, at the same time, file a written
request for a hearing on such
application pursuant to 21 CFR 1301.43
and in such form as prescribed by 21
CFR 1316.47.
VerDate Nov<24>2008
16:39 Jun 25, 2009
Jkt 217001
Any such comments or objections
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, VA 22152; and must be
filed no later than July 27, 2009.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substance listed in
schedule I or II are, and will continue
to be, required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: June 22, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–15233 Filed 6–25–09; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on March 19, 2009,
Wildlife Laboratories Inc., 1401 Duff
Drive, Suite 400, Fort Collins, Colorado
80524, made application to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Carfentanil (9743), a basic class of
controlled substance listed in schedule
II.
The company will manufacture the
above listed controlled substance for
sale to veterinary pharmacies, zoos, and
for other animal and wildlife
applications.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such a substance,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such comments or objections
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
PO 00000
Frm 00122
Fmt 4703
Sfmt 4703
30621
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than August 25, 2009.
Dated: June 22, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–15235 Filed 6–25–09; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Employment and Training
Administration
Notice of a Change in Status of an
Extended Benefit (EB) Period for
Colorado
AGENCY: Employment and Training
Administration, Labor.
ACTION: Notice.
SUMMARY: This notice announces a
change in benefit period eligibility
under the EB program for Colorado.
The following change has occurred
since the publication of the last notice
regarding Colorado’s EB status:
• Colorado has modified its law by
adding a total unemployment rate (TUR)
trigger retroactive to March 22, 2009. As
a result, Colorado has retroactively
triggered ‘‘on’’ to an extended benefit
period for weeks of unemployment
beginning April 12, 2009, and eligible
unemployed workers will be able to
collect up to an additional 13 weeks of
unemployment insurance benefits.
Information for Claimants
The duration of benefits payable in
the EB program, and the terms and
conditions on which they are payable,
are governed by the Federal-State
Extended Unemployment Compensation
Act of 1970, as amended, and the
operating instructions issued to the
states by the U.S. Department of Labor.
In the case of a state beginning an EB
period, the State Workforce Agency will
furnish a written notice of potential
entitlement to each individual who has
exhausted all rights to regular benefits
and is potentially eligible for EB (20
CFR 615.13(c)(1)). Persons who believe
they may be entitled to EB or who wish
to inquire about their rights under the
program should contact their State
Workforce Agency.
FOR FURTHER INFORMATION CONTACT:
Scott Gibbons, U.S. Department of
Labor, Employment and Training
Administration, Office of Workforce
Security, 200 Constitution Avenue,
NW., Frances Perkins Building, Room
S–4231, Washington, DC 20210,
E:\FR\FM\26JNN1.SGM
26JNN1
Agencies
[Federal Register Volume 74, Number 122 (Friday, June 26, 2009)]
[Notices]
[Pages 30620-30621]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-15228]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this
is notice that on May 8, 2009, Chattem Chemicals, Inc., 3801 St. Elmo
Avenue, Building 18, Chattanooga, Tennessee 37409, made application by
renewal to the Drug Enforcement Administration (DEA) for registration
as an importer of the basic classes of controlled substances listed in
schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Methamphetamine (1105)..................... II
Phenylacetone (8501)....................... II
Raw Opium (9600)........................... II
Concentrate of Poppy Straw (9670).......... II
------------------------------------------------------------------------
The company plans to import the listed controlled substances to
manufacture bulk controlled substances for sale to its customers.
No comments, objections, or requests for any hearings will be
accepted on any application for registration or re-registration to
import crude opium, poppy straw, concentrate of poppy straw, and coca
leaves. As explained in the Correction to Notice of Application
pertaining to Rhodes Technologies, 72 FR 3417 (2007), comments and
requests for hearings on applications to import narcotic raw material
are not appropriate.
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic classes of controlled
substances listed in schedule I or II, which fall under the authority
of section 1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may, in
the circumstances set forth in 21 U.S.C. 958(i), file comments or
objections to the issuance of the proposed registration and may, at the
same time, file a written request for a hearing on such application
pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR
1316.47.
Any such comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than July 27, 2009.
This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21 CFR
[[Page 30621]]
1301.34(b), (c), (d), (e), and (f). As noted in a previous notice
published in the Federal Register on September 23, 1975, (40 FR 43745-
46), all applicants for registration to import a basic class of any
controlled substances in schedule I or II are, and will continue to be,
required to demonstrate to the Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement Administration, that the
requirements for such registration pursuant to 21 U.S.C. 958(a), 21
U.S.C. 823(a), and 21 CFR Sec. 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: June 22, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-15228 Filed 6-25-09; 8:45 am]
BILLING CODE 4410-09-M